Iguana Healthcare Management Llc increased Cymabay Therapeutics Inc (CBAY) stake by 138.1% reported in 2017Q3 SEC filing. Iguana Healthcare Management Llc acquired 145,000 shares as Cymabay Therapeutics Inc (CBAY)’s stock rose 21.05%. The Iguana Healthcare Management Llc holds 250,000 shares with $2.02 million value, up from 105,000 last quarter. Cymabay Therapeutics Inc now has $403.55 million valuation. The stock increased 1.66% or $0.15 during the last trading session, reaching $9.2. About 730,735 shares traded or 12.33% up from the average. Cymabay Therapeutics, Inc. (NASDAQ:CBAY) has risen 69.26% since January 1, 2017 and is uptrending. It has outperformed by 52.56% the S&P500.
Autohome Incorporated (NYSE:ATHM) had a decrease of 4.49% in short interest. ATHM’s SI was 2.76 million shares in January as released by FINRA. Its down 4.49% from 2.89 million shares previously. With 899,300 avg volume, 3 days are for Autohome Incorporated (NYSE:ATHM)’s short sellers to cover ATHM’s short positions. The stock increased 0.33% or $0.21 during the last trading session, reaching $64.67. About 243,981 shares traded. Autohome Inc. (NYSE:ATHM) has risen 72.98% since January 1, 2017 and is uptrending. It has outperformed by 56.28% the S&P500.
Iguana Healthcare Management Llc decreased Dermira Inc (NASDAQ:DERM) stake by 15,000 shares to 125,000 valued at $3.38 million in 2017Q3. It also reduced Zogenix Inc stake by 65,000 shares and now owns 20,000 shares. Avexis Inc was reduced too.
Among 6 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 16 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, November 28, the company rating was maintained by Leerink Swann. H.C. Wainwright initiated Cymabay Therapeutics, Inc. (NASDAQ:CBAY) on Tuesday, September 8 with “Buy” rating. Cantor Fitzgerald initiated Cymabay Therapeutics, Inc. (NASDAQ:CBAY) rating on Tuesday, September 19. Cantor Fitzgerald has “Buy” rating and $16.0 target. The firm earned “Neutral” rating on Wednesday, June 1 by H.C. Wainwright. The firm has “Buy” rating by Roth Capital given on Friday, July 1. H.C. Wainwright maintained the shares of CBAY in report on Monday, July 17 with “Buy” rating. Piper Jaffray maintained Cymabay Therapeutics, Inc. (NASDAQ:CBAY) on Monday, September 11 with “Buy” rating. H.C. Wainwright maintained the shares of CBAY in report on Wednesday, March 30 with “Buy” rating. The firm has “Buy” rating by Piper Jaffray given on Monday, July 17. The firm has “Neutral” rating given on Wednesday, January 4 by H.C. Wainwright.
The post Iguana Healthcare Management Has Increased Its Cymabay Therapeutics (CBAY) Stake; Autohome (ATHM) Sellers Decreased By 4.49% Their Shorts appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/01/01/iguana-healthcare-management-has-increased-its-cymabay-therapeutics-cbay-stake-autohome-athm-sellers-decreased-by-4-49-their-shorts/
No comments:
Post a Comment